S54 The effects of E-cigarettes on pulmonary inflammation and inflammasome activation. (December 2018)
- Record Type:
- Journal Article
- Title:
- S54 The effects of E-cigarettes on pulmonary inflammation and inflammasome activation. (December 2018)
- Main Title:
- S54 The effects of E-cigarettes on pulmonary inflammation and inflammasome activation
- Authors:
- Bell, RL
O'Kane, C
Shyamsundar, M
Dombrowski, Y - Abstract:
- Abstract : Introduction and aims: E-cigarettes are marketed as an aid to quit smoking, but nothing is known about their effects on health. Cigarette smoke is known to activate a group of intracellular complexes called inflammasomes, releasing pro-inflammatory IL-18 and IL-1beta via caspase-1 cleavage. Studies have shown chemicals in vaporised E-liquids also found in cigarette smoke. E-liquids have been shown to increase cellular ROS generation and inflammatory cytokine release suggesting that E-cigarette usage might activate inflammasomes. We aim to assess the effect of E-liquid on human pulmonary cells and hypothesise that E-cigarette use induces pulmonary inflammation and inflammasome activation. Methods: To establish models, alveolar epithelial-like cells (A549) and monocyte derived macrophages (THP-1) were used. Additionally, primary human macrophages where isolated from blood. Cells were stimulated either with E-liquids or E-Liquid that had been vaporised and dissolved in cell culture medium. E-liquid was dripped in at 0.3% V/V and vapour was dissolved at a concentration equal to a previously used model for cigarette smoke extract. Supernatants where collected at 2, 4, 24, 48 and 72 hours. Cells where lysed and fixed. Markers of inflammasome activation (IL-1beta, IL-18, caspase-1) and general markers of inflammatory response (IL-8, IL-6) were analysed by ELISA and Western blot. Inflammasome activation was assessed by Apoptosis associated Speck like protein (ASC), anAbstract : Introduction and aims: E-cigarettes are marketed as an aid to quit smoking, but nothing is known about their effects on health. Cigarette smoke is known to activate a group of intracellular complexes called inflammasomes, releasing pro-inflammatory IL-18 and IL-1beta via caspase-1 cleavage. Studies have shown chemicals in vaporised E-liquids also found in cigarette smoke. E-liquids have been shown to increase cellular ROS generation and inflammatory cytokine release suggesting that E-cigarette usage might activate inflammasomes. We aim to assess the effect of E-liquid on human pulmonary cells and hypothesise that E-cigarette use induces pulmonary inflammation and inflammasome activation. Methods: To establish models, alveolar epithelial-like cells (A549) and monocyte derived macrophages (THP-1) were used. Additionally, primary human macrophages where isolated from blood. Cells were stimulated either with E-liquids or E-Liquid that had been vaporised and dissolved in cell culture medium. E-liquid was dripped in at 0.3% V/V and vapour was dissolved at a concentration equal to a previously used model for cigarette smoke extract. Supernatants where collected at 2, 4, 24, 48 and 72 hours. Cells where lysed and fixed. Markers of inflammasome activation (IL-1beta, IL-18, caspase-1) and general markers of inflammatory response (IL-8, IL-6) were analysed by ELISA and Western blot. Inflammasome activation was assessed by Apoptosis associated Speck like protein (ASC), an adaptor protein in inflammasome formation, in ASC-reporter cells. Cytotoxicity was determined by lactate dehydrogenase (LDH) release. Results: E-liquid containing nicotine induced 60% (SD=8.387) cell death in THP-1 macrophages compared to negative control at 35% (SD=0.723) (n=3, p<0.05). Vaporised Cinnamon flavoured E-liquid induced 59% (SD=30.500) cell death in epithelial cells compared to negative controls at 15% (SD=2.153) and 91% (SD=10.710) cell death in THP-1 macrophages compared to negative controls at 44% (SD=2.730) (n=3, p<0.05). An average increase of 25 inflammasomes formed per field of view, as measured by ASC speck formation, is seen when THP-1 cells are treated with LPS and vaporised E-liquid for 2 hours compared to LPS alone (n=4). Conclusion: E-cigarettes have the potential to cause pulmonary cytotoxicity and increase immune responses to bacterial and microbial pathogens such as LPS via inflammasome activation. … (more)
- Is Part Of:
- Thorax. Volume 73(2018)Supplement 4
- Journal:
- Thorax
- Issue:
- Volume 73(2018)Supplement 4
- Issue Display:
- Volume 73, Issue 4 (2018)
- Year:
- 2018
- Volume:
- 73
- Issue:
- 4
- Issue Sort Value:
- 2018-0073-0004-0000
- Page Start:
- A32
- Page End:
- A33
- Publication Date:
- 2018-12
- Subjects:
- Chest -- Diseases -- Periodicals
Thorax
Chest -- Diseases
Periodicals
Periodicals
617.54 - Journal URLs:
- http://thorax.bmjjournals.com/contents-by-date.0.shtml ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/thorax-2018-212555.60 ↗
- Languages:
- English
- ISSNs:
- 0040-6376
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19880.xml